Proteomics analysis of cerebrospinal fluid to investigate brain involvement in pre-eclampsia

Proteomics analysis of cerebrospinal fluid to investigate brain involvement in pre-eclampsia - LEPRA II (liquor cerebrospinalis and pre-eclampsia)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON43723

Enrollment

Registered

2015-10-15

Start date

2016-07-19

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neurologische aandoeningen tijdens de zwangerschap pre-eclampsia

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Non pregnant women of 18 year and older

Exclusion criteria

Exclusion criteria: Pregnant during inclusion Pre-eclampsia in history Auto-immune disorders Oral corticosteroid use Hemoglobinopathy or clotting disorder Chronic hypertension or proteinuria Kidney disorders Neurologic disorder

Design outcomes

Primary

Measure	Time frame
The present research aims to obtain a control group of women who are not pregnant and do not have pre-eclampsia. The outcome measure of the previous research project was pre-eclampsia: a blood pressure * 140 mmHg (systolic) and * 90mmHg (diastolic) during at least two measurements after 20 weeks of pregnancy in combination with proteinuria (* 300 mg / 24 hours or protein / creatinine ratio of * 30 mg / mmol).	—

Measure

Time frame

The present research aims to obtain a control group of women who are not pregnant and do not have pre-eclampsia. The outcome measure of the previous research project was pre-eclampsia: a blood pressure * 140 mmHg (systolic) and * 90mmHg (diastolic) during at least two measurements after 20 weeks of pregnancy in combination with proteinuria (* 300 mg / 24 hours or protein / creatinine ratio of * 30 mg / mmol).

—

Countries

Netherlands

Outcome results